Cardiol Therapeutics Variance
| CRDL Stock | | | CAD 1.50 0.05 3.45% |
The Variance signal for Cardiol Therapeutics Class reflects patterns observed in trading data. Availability can differ across markets, exchanges, and instruments. Cardiol Therapeutics has a market cap of 161.94 M, current ratio of 24.67.
Trending Equities can help frame allocation decisions. Cardiol Therapeutics Class can be tracked within a custom portfolio for ongoing monitoring. Watchlist features allow monitoring without committing to a position. Broader economic conditions can influence Cardiol Therapeutics Class's company valuation — related indicators include
signals in inflation.
Cardiol Therapeutics Class has current Variance of 11.86. Variance is another measure of security risk that shows the amount of dispersion of equity returns around their mean value. Variance is calculated as the average squared deviations from the mean. Evaluating a set of investment alternatives one can use variance to help determine the volatility when purchasing a specific security. Similar to Standard Deviation, the variance is a measure of how far a set of numbers is spread out around its mean.
Variance | = | SUM(RET DEV)2N |
| = | 11.86 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual returns deviation over selected period |
| N | = | Number of points for the period |
Variance Peers Comparison
Variance Relative To Other Indicators
Cardiol Therapeutics Class lands at
#3 in variance compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors producing
1.52 in Maximum Drawdown for each unit of Variance. The spread between Maximum Drawdown and Variance for Cardiol Therapeutics Class sits at
1.52 Variance is also a measure of stock volatility and can help determine the risk an investor might take on when purchasing a specific security. A relatively big variance indicates that the daily prices or returns are far from the mean and a small variance indicates that they are located around the mean.
Compare Cardiol Therapeutics to Peers
Other Technical Indicators